Trip of Compassion: A window into psychedelic-assisted therapies – Canberra · Mind Medicine Australia
Mind Medicine Australia logo
Donate

Trip of Compassion: A window into psychedelic-assisted therapies – Canberra

With Tania de Jong AM, Peter Hunt AM and Admiral Chris Barrie AC​

Date: Wed 03 March 2021 @ 6:30pm
Location: Canberra

Don’t miss out – Canberra’s FIRST screening of the world acclaimed film – Trip of Compassion.

Our previous viewings have sold out within days of being announced. Be sure to grab your tickets early!

Mind Medicine Australia is thrilled to welcome you to Canberra’s’ premiere screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapies sessions.

I felt like I went through 15 years of psychological therapy in one night.
–  Patient featured in Trip of Compassion

You can watch the preview here:

Following the screening, there will be a Q & A panel with Tania de Jong AM, Peter Hunt AM and Admiral Chris Barrie AC. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Trip of Compassion is the most compelling movie I’ve seen in the last  year!
– Tim Ferris, acclaimed author and podcaster

Director: Gil Karni,
Producers: Zafrir Kochanovsky & Miri Ezra – ttv Productions
Distributors: GO2FILMS

DATE: Wednesday 3rd of March 2020 – 6:30pm

Location: Palace Electric Cinema, 2 Phillip Law Street, Canberra ACT,

The theatre will open at 6:00pm for 6:30pm start – 8:50pm (incl Q&A Panel)
Ticket Price: $30 EARLY BIRD (ends 19 February) / 35 General Admission / $25 Concession

More about medicinal MDMA

Psychedelic-assisted therapies offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

The Presenters

Tania de Jong AM

LL.B (Hons), GradDipMus

Co-founder Mind Medicine Australia, Founder Creative Universe, Creativity Australia, The Song Room & Creative Innovation Global

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Admiral Chris Barrie AC​

MBA

Admiral Chris Barrie commanded all arms of the Defence Force as its Chief (CDF) from 1998 till 2002. After this, Chris worked on strategic leadership as a consultant, teacher and mentor, initially through Oxford University’s Strategic Leadership and Stimulus Forum Programs (2002-2011); and as Distinguished Visiting Professor he also taught an elective on Strategic Leadership to senior U.S. military officers at the National Defense University in Washington DC from 2004 till 2010.

He is busy now as the founder and Chair of Fearless- PTSD (Australia New Zealand), whose subsidiary ‘FearLess Outreach’ is intended to assist an estimated 6 million people in the Australian and New Zealand communities, who live with post-traumatic stress. He is an outspoken commentator on Climate Change and Security using community advocacy to raise awareness of the potential costs of inaction. Chris is also the Australian member of the Global Military Advisory Council on Climate Change (GMACCC), and an adjunct member of the Planetary Security Initiative based in the Hague.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×